The Japan medical devices market was valued at USD 49.74 Billion in 2025, driven by advanced healthcare infrastructure, high R&D capabilities, and strong regulatory standards that ensure quality and safety across the region. It is expected to grow at a CAGR of 5.60% during the forecast period of 2026-2035 and attain a market value of USD 85.77 Billion by 2035.
Japan’s reputation for precision engineering and technological innovation further strengthens the development and global competitiveness of medical equipment produced in the country. Devices made in Japan are often characterized by their accuracy, reliability, and high-quality manufacturing, which has made them highly sought after in international markets. The country’s focus on producing devices that cater to both the domestic and global demand for advanced medical solutions will continue to fuel market expansion during the forecast period.
Base Year
Historical Period
Forecast Period
Japan’s aging population and rising chronic disease cases are driving consistent demand for advanced medical technologies and devices.
Strong government support and favorable regulatory reforms are expected to boost innovation and domestic medical device production capabilities.
Increased global partnerships and overseas investments by Japanese firms are enhancing market reach and supply chain resilience.
Compound Annual Growth Rate
5.6%
Value in USD Billion
2026-2035
*this image is indicative*
Medical devices are essential tools in Japan’s healthcare system, supporting diagnosis, treatment, and patient monitoring across various specialties. With a rapidly aging population and rising chronic conditions such as cardiovascular diseases and diabetes, the demand for advanced, minimally invasive, and home-care devices is increasing. These technologies improve patient outcomes, reduce hospital stays, and enhance quality of life. Japan’s focus on healthcare innovation and digital integration further underscores the critical need for medical devices to meet evolving public health challenges. The market is expected to grow at a CAGR of 5.60% during the forecast period of 2026-2035 and attain a market value of USD 85.77 Billion by 2035.
Launch of Innovative Devices to Drive Market Expansion
Rising cardiovascular disease prevalence and demand for improved surgical solutions are key drivers in Japan’s medical device market. For instance, in May 2024, Teijin Limited, in collaboration with Fukui Tateami Co., Ltd. and Osaka Medical and Pharmaceutical University, announced the launch of SYNFOLIUM®, a new cardiovascular surgical patch for congenital heart disease. This innovative product’s tissue integration and growth adaptability features are expected to enhance treatment outcomes, stimulating market growth throughout the forecast period.
Strategic Healthcare Acquisitions to Enhance Japan Medical Devices Market Demand
Expanding healthcare infrastructure and increasing demand for cardiovascular devices are fueling market consolidation in Japan. For instance, in March 2025, Tokyo-based ORIX Corporation acquired Apex Holdings Co., Ltd., a prominent cardiovascular device distributor serving major hospitals. This acquisition strengthens ORIX’s healthcare portfolio, enabling improved procurement and sales efficiency. It is set to boost market development and elevate the overall value of Japan’s medical device sector during the forecast period.
The market is advancing through material innovation and strategic overseas manufacturing investments.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Cardiology to Account for a Significant Market Share in the Segmentation by Application
Cardiovascular diseases (CVDs) remain a significant health concern in Japan, particularly due to the nation's aging population. In 2021, Japan reported 371,917 deaths attributed to CVDs, highlighting their substantial impact on public health. While age-adjusted mortality rates have shown a declining trend, the crude mortality rate for heart disease has been increasing annually, reflecting the demographic shift towards an older population. The prevalence of heart failure is projected to reach 1.3 million by 2030, underscoring the growing burden of chronic cardiovascular conditions. These trends emphasize the critical need for advanced cardiovascular care and the development of innovative medical devices to address the evolving healthcare demands in Japan.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Dublin, Ireland, and founded in 1949, Medtronic plc is one of the world’s largest medical device companies. It operates a significant presence in Japan, offering innovative technologies across cardiovascular, diabetes, neurological, and surgical sectors. Medtronic Japan delivers advanced solutions such as pacemakers, insulin pumps, and spinal implants, aligned with the country’s growing need for chronic disease management and minimally invasive procedures. The company actively collaborates with Japanese healthcare providers to support patient-centric innovations and improve clinical outcomes.
Johnson & Johnson MedTech, a division of the U.S.-based Johnson & Johnson established in 1886, has a robust footprint in Japan. Headquartered in New Brunswick, New Jersey, it offers a diverse medical devices portfolio including orthopedics, surgical technologies, cardiovascular care, and vision products. In Japan, the company operates through Ethicon, DePuy Synthes, and Biosense Webster, providing cutting-edge solutions that cater to the country's aging population and rising demand for minimally invasive surgery and interventional technologies.
Fresenius Medical Care AG & Co., headquartered in Bad Homburg, Germany, was founded in 1996 and is a global leader in dialysis care and renal technologies. In Japan, the company provides comprehensive dialysis products and services, including hemodialysis machines, dialyzers, and related therapies. Its operations align with Japan’s high prevalence of end-stage renal disease. Fresenius continues to invest in advanced treatment solutions and local partnerships, ensuring efficient patient care and contributing to the nation’s renal healthcare infrastructure.
Abbott, a U.S.-based healthcare company established in 1888 and headquartered in Abbott Park, Illinois, maintains a strong presence in Japan’s medical device market. Its diverse product range includes cardiovascular devices, diagnostics, diabetes care, and neuromodulation technologies. Abbott Japan is well known for its innovations in heart failure management, glucose monitoring systems like FreeStyle Libre, and implantable devices. With a focus on preventive care and disease monitoring, the company addresses Japan’s aging demographic and growing burden of chronic diseases.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, and 3M Company, among others.
Upto 15% Off
USD
$3099 $2789
$1999 $1799
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share